Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Jan 26, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping mothers who are experiencing postpartum depression (PPD), a condition that can affect their bond with their babies and the baby's development. The study is testing a special program called HUGS (Happiness Understanding Giving and Sharing) to see if it can improve the relationship between mothers and their infants. The trial is currently looking for women who have recently given birth and have been diagnosed with PPD. Eligible participants must have started treatment for their depression at least 8 weeks ago and show some signs of improvement. Their babies should be less than one year old to join the study.
If you or someone you know might qualify, participants will need to provide written consent and meet certain criteria, such as not having severe mental health issues or substance use problems. The study aims to provide support to mothers and enhance their connection with their babies during a critical time. It's essential to know that this study is open to mothers who speak French and that mothers with twins can also participate. Overall, this trial seeks to make a positive impact on both the mothers’ well-being and their babies’ development.
Gender
FEMALE
Eligibility criteria
- Inclusion criteria regarding the mother:
- • Person affiliated or beneficiary of a social security plan;
- • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research);
- • Woman who gave birth in one of the maternity hospitals participating in the study;
- • Diagnosis of postpartum depression made by the perinatal psychiatry team according to the clinical criteria of the DSM-5;
- • Time to onset of depressive symptoms within the first 12 months after childbirth;
- • Treatment for postpartum depression that started at least 8 weeks ago with improved mood as assessed by the psychiatrist.
- Inclusion criteria for the baby:
- • Baby aged less than 1 year at inclusion;
- • Twins will be able to participate in the study and benefit from the interventions;
- Non-inclusion criteria concerning the mother:
- • Uncontrolled substance use disorder;
- • Presence of suicidal ideas at inclusion;
- • Manic episode of a bipolar disease
- • Psychiatric pathology decompensated upon inclusion and corresponding to the following list: Schizophrenic disorder, Schizoaffective disorder, Mood disorders with psychotic symptoms;
- • Non French speaker.
- Non-inclusion criteria for the baby:
- • - Baby hospitalized or having sustained medical care upon inclusion in the context of a somatic pathology.
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Le Havre, , France
Reims, , France
Rouen, , France
Toulouse, , France
Toulouse, , France
Toulouse, , France
Patients applied
Trial Officials
Carole GENTILLEAU, MD
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials